Search

Displaying all 4 results
DrugBest match

Belantamab mafodotin

go.drugbank.com/drugs/DB15719
ApprovedInvestigationalWithdrawn

Belantamab mafodotin, or GSK2857916, is an afucosylated monoclonal antibody that targets B cell maturation antigen conjugated to the microtubule disrupter monomethyl auristatin-F (MMAF). Belantamab mafodotin was granted FDA accelerated approval on 5 August 2020 for the treatment of multiple myeloma; however, its man...

  1. Indication

    Relapsed/Refractory Multiple Myeloma (RRMM)

    go.drugbank.com/conditions/DBCOND0111386
    Drugs: Belantamab mafodotin · Carfilzomib · Melphalan flufenamide
  2. Indication

    Relapsed Multiple Myeloma

    go.drugbank.com/conditions/DBCOND0031510
    Drugs: Belantamab mafodotin · Carfilzomib · Ciltacabtagene autoleucel · Daratumumab · Dexamethasone · Elranatamab +8 more
  3. Indication

    Refractory Multiple Myeloma

    go.drugbank.com/conditions/DBCOND0028542
    Drugs: Belantamab mafodotin · Carfilzomib · Carmustine · Ciltacabtagene autoleucel · Daratumumab · Dexamethasone +11 more